{"id":"https://openalex.org/W4236422406","doi":"https://doi.org/10.1016/j.ygyno.2020.05.152","title":"Characterization of isogenic ovarian cancer cell line models of acquired resistance to the clinical ATR inhibitor AZD6738","display_name":"Characterization of isogenic ovarian cancer cell line models of acquired resistance to the clinical ATR inhibitor AZD6738","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W4236422406","doi":"https://doi.org/10.1016/j.ygyno.2020.05.152"},"language":"en","primary_location":{"id":"doi:10.1016/j.ygyno.2020.05.152","doi":"https://doi.org/10.1016/j.ygyno.2020.05.152","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2020.05.152","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082378333","display_name":"W. Ao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Ao","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087130203","display_name":"Domenic Tommarello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Tommarello","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003651382","display_name":"K.A. Conrads","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K.A. Conrads","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057704579","display_name":"P.N. Teng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P.N. Teng","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038326888","display_name":"Neil T. Phippen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N.T. Phippen","raw_affiliation_strings":["San Antonio Military Medical Center, Fort Sam Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Antonio Military Medical Center, Fort Sam Houston, TX, USA","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112840989","display_name":"K.M. Darcy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K.M. Darcy","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","John P. Murtha Cancer Center, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"John P. Murtha Cancer Center, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103268869","display_name":"Chad A. Hamilton","orcid":"https://orcid.org/0000-0002-2940-5998","observed_orcids":["https://orcid.org/0000-0002-2940-5998"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.A. Hamilton","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072598455","display_name":"Y. Casablanca","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Casablanca","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","John P. Murtha Cancer Center, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"John P. Murtha Cancer Center, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039063051","display_name":"Chris J. Bakkenist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.J. Bakkenist","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000738137","display_name":"John Ian Risinger","orcid":"https://orcid.org/0000-0003-1280-1326","observed_orcids":["https://orcid.org/0000-0003-1280-1326"]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.I. Risinger","raw_affiliation_strings":["Michigan State University, Grand Rapids, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Michigan State University, Grand Rapids, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108696376","display_name":"G. Larry Maxwell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800468613","display_name":"Inova Fairfax Hospital","ror":"https://ror.org/0212h5y77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498","https://openalex.org/I2800468613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G.L. Maxwell","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","Inova Fairfax Hospital, Falls Church, VA, USA","John P. Murtha Cancer Center, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"Inova Fairfax Hospital, Falls Church, VA, USA","institution_ids":["https://openalex.org/I2800468613"]},{"raw_affiliation_string":"John P. Murtha Cancer Center, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080595928","display_name":"Thomas P. Conrads","orcid":"https://orcid.org/0000-0003-4742-3281","observed_orcids":["https://orcid.org/0000-0003-4742-3281"]},"institutions":[{"id":"https://openalex.org/I2800468613","display_name":"Inova Fairfax Hospital","ror":"https://ror.org/0212h5y77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498","https://openalex.org/I2800468613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T.P. Conrads","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","Inova Fairfax Hospital, Falls Church, VA, USA","John P. Murtha Cancer Center, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"Inova Fairfax Hospital, Falls Church, VA, USA","institution_ids":["https://openalex.org/I2800468613"]},{"raw_affiliation_string":"John P. Murtha Cancer Center, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027846079","display_name":"N.W. Bateman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"N.W. Bateman","raw_affiliation_strings":["Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","John P. Murtha Cancer Center, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Cancer Center of Excellence, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"John P. Murtha Cancer Center, Bethesda, MD, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5027846079"],"corresponding_institution_ids":[],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.27891819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"159","issue":null,"first_page":"125","last_page":"126"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.06780000030994415,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.03240000084042549,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atr-inhibitors","display_name":"ATR inhibitors","score":0.8169999718666077},{"id":"https://openalex.org/keywords/azd6738","display_name":"AZD6738","score":0.9660000205039978},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.8450000286102295},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9139999747276306},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.6169999837875366},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7452321648597717},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.554779052734375},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5271898508071899},{"id":"https://openalex.org/C2994372470","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell lines","level":4,"score":0.47824278473854065},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4333682656288147},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.35438528656959534},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23129141330718994}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ygyno.2020.05.152","doi":"https://doi.org/10.1016/j.ygyno.2020.05.152","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2020.05.152","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386196619","https://openalex.org/W2886446951","https://openalex.org/W2315307800","https://openalex.org/W3123248651","https://openalex.org/W4283075446","https://openalex.org/W3195042240","https://openalex.org/W7221691053","https://openalex.org/W2886859135","https://openalex.org/W3012597146","https://openalex.org/W38229466"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-05-12T00:00:00"}